198
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Dyslipidemia

, , , , , , , , , , & ORCID Icon show all
Pages 5573-5579 | Published online: 14 Sep 2021

References

  • Kopin L, Lowenstein C. Dyslipidemia. Ann Intern Med. 2017;167(11):ITC81–ITC96. doi:10.7326/AITC201712050
  • Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150–159. doi:10.1038/ncpendmet1066
  • Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y. Effects of statins on serum inflammatory markers: the U.S. national health and nutrition examination survey 1999–2004. J Atheroscler Thromb. 2010;17(11):1176–1182. doi:10.5551/jat.5652
  • Andersen CJ. Impact of dietary cholesterol on the pathophysiology of infectious and autoimmune disease. Nutrients. 2018;10(6):764. doi:10.3390/nu10060764
  • Kritikou E, van der Heijden T, Swart M, et al. Hypercholesterolemia induces a mast cell-CD4+ T cell interaction in atherosclerosis. J Immunol. 2019;202(5):1531–1539. doi:10.4049/jimmunol.1800648
  • Giugliano G, Brevetti G, Lanero S, Schiano V, Laurenzano E, Chiariello M. Leukocyte count in peripheral arterial disease: a simple, reliable, inexpensive approach to cardiovascular risk prediction. Atherosclerosis. 2010;210(1):288–293. doi:10.1016/j.atherosclerosis.2009.11.009
  • Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122(18):1837–1845. doi:10.1161/CIRCULATIONAHA.110.961714
  • Tay MHD, Lim SYJ, Leong YFI, et al. Halted lymphocyte egress via efferent lymph contributes to lymph node hypertrophy during hypercholesterolemia. Front Immunol. 2019;10:575. doi:10.3389/fimmu.2019.00575
  • Corbi SCT, de Vasconcellos JF, Bastos AS, et al. Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis. Sci Rep. 2020;10(1):8145. doi:10.1038/s41598-020-65042-9
  • Guasti L, Maresca AM, Schembri L, et al. Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment. BMC Cardiovasc Disord. 2016;16:26. doi:10.1186/s12872-016-0201-y
  • Liu Y, Kong X, Wang W, et al. Association of peripheral differential leukocyte counts with dyslipidemia risk in Chinese patients with hypertension: insight from the China stroke primary prevention trial. J Lipid Res. 2017;58(1):256–266. doi:10.1194/jlr.P067686
  • Genkel V, Dolgushin I, Baturina I, et al. Associations between hypertriglyceridemia and circulating neutrophil subpopulation in patients with dyslipidemia. Int J Inflam. 2021;2021:6695468. doi:10.1155/2021/6695468
  • Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7(1):66–75. doi:10.3945/an.115.010207
  • Pirillo A, Catapano AL, Norata GD. HDL in infectious diseases and sepsis. Handb Exp Pharmacol. 2015;224:483–508. doi:10.1007/978-3-319-09665-0_15
  • Andersen CJ, Lee JY, Blesso CN, Carr TP, Fernandez ML. Egg intake during carbohydrate restriction alters peripheral blood mononuclear cell inflammation and cholesterol homeostasis in metabolic syndrome. Nutrients. 2014;6(7):2650–2667. doi:10.3390/nu6072650
  • Thompson PA, Kitchens RL. Native high-density lipoprotein augments monocyte responses to lipopolysaccharide (LPS) by suppressing the inhibitory activity of LPS-binding protein. J Immunol. 2006;177(7):4880–4887. doi:10.4049/jimmunol.177.7.4880
  • Ma SD, Mussbacher M, Galkina EV. Functional role of B cells in atherosclerosis. Cells. 2021;10(2):270. doi:10.3390/cells10020270
  • Wang F, Beck-García K, Zorzin C, Schamel WW, Davis MM. Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol. Nat Immunol. 2016;17(7):844–850. doi:10.1038/ni.3462
  • Bagley J, Yuan J, Chandrakar A, Iacomini J. Hyperlipidemia alters regulatory T cell function and promotes resistance to tolerance induction through costimulatory molecule blockade. Am J Transplant. 2015;15(9):2324–2335. doi:10.1111/ajt.13351
  • Mailer RKW, Gisterå A, Polyzos KA, Ketelhuth DFJ, Hansson GK. Hypercholesterolemia enhances T cell receptor signaling and increases the regulatory T cell population. Sci Rep. 2017;7(1):15655. doi:10.1038/s41598-017-15546-8
  • Maganto-García E, Tarrio ML, Grabie N, Bu DX, Lichtman AH. Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation. 2011;124(2):185–195. doi:10.1161/CIRCULATIONAHA.110.006411
  • Baardman J, Lutgens E. Regulatory T cell metabolism in atherosclerosis. Metabolites. 2020;10(7):279. doi:10.3390/metabo10070279